300018 logo

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Stock Price

SZSE:300018 Community·CN¥5.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

300018 Share Price Performance

CN¥0
-7.90 (-100.00%)
CN¥0
-7.90 (-100.00%)
Price CN¥0

300018 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record and pays a dividend.

2 Risks
2 Rewards

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Key Details

CN¥678.6m

Revenue

CN¥357.4m

Cost of Revenue

CN¥321.1m

Gross Profit

CN¥179.0m

Other Expenses

CN¥142.2m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 18, 2026
0.29
47.32%
20.95%
0%
View Full Analysis

About 300018

Founded
2001
Employees
779
CEO
n/a
WebsiteView website
www.zyhd.com.cn

Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd., together with its subsidiaries, engages in the smart grid, healthcare, and industrial investment businesses in China. The company offers power system dynamic recording systems, power system time synchronization and measurement systems, smart grid instruments, integrated automation systems, smart distribution network dispatching and integrated automation systems, energy internet system integration, and intelligent equipment; and fault recording waveform, time synchronization, power grid monitoring, information systems, intelligent inspection, power system relay protection testing and distribution network testing equipment, power data recording and analysis equipment, power time measurement and time scale output equipment, and power system integrated testing equipment. It also provides maintenance, commissioning, and operation services for substations and distribution networks; planning, design, consulting, operation, and maintenance services for energy internet; and after-sales services. In addition, the company engages in the research, development, production, sale, and service of medical informatics and clinical in vitro diagnostics products, including biochemical in vitro diagnostic reagents and medical testing equipment; and mergers and acquisitions, as well as investment activities. Further, it is involved in software development; power equipment manufacturing; non-securities investments; and medical software. The company was founded in 2001 and is headquartered in Wuhan, China.

Recent 300018 News & Updates

Recent updates

No updates